Exact Mass: 567.304331

Exact Mass Matches: 567.304331

Found 28 metabolites which its exact mass value is equals to given mass value 567.304331, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Nelfinavir

(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide

C32H45N3O4S (567.3130610000001)


Nelfinavir is only found in individuals that have used or taken this drug. It is a potent HIV-1 protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children. [PubChem]Nelfinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

   
   

Tetradehydrolongicaudatine Y

Tetradehydrolongicaudatine Y

C38H39N4O (567.3123704)


   

Nelfinavir

Nelfinavir

C32H45N3O4S (567.3130610000001)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

   

3,4,5,6-tetradehydrolongicaudatine Y

3,4,5,6-tetradehydrolongicaudatine Y

[C38H39N4O]+ (567.3123704)


   

cataCXium(R) FPrPh,Dicyclohexyl[9-(3-phenylpropyl)-9-fluorenyl]phosphine tetrafluoroborate

cataCXium(R) FPrPh,Dicyclohexyl[9-(3-phenylpropyl)-9-fluorenyl]phosphine tetrafluoroborate

C34H41BF4P (567.2974893999999)


   

HG-9-91-01

1-(2,4-Dimethoxyphenyl)-3-(2,6-dimethylphenyl)-1-[6-[4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]urea

C32H37N7O3 (567.2957732)


   

3-[[(2R)-2-hydroxypropyl]amino]-3-methyl-N-[(3R)-2-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4,5-dihydro-3H-1-benzazepin-3-yl]butanamide

3-[[(2R)-2-hydroxypropyl]amino]-3-methyl-N-[(3R)-2-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4,5-dihydro-3H-1-benzazepin-3-yl]butanamide

C32H37N7O3 (567.2957732)


   
   

3,4,5,6-tetradehydrolongicaudatine Y

3,4,5,6-tetradehydrolongicaudatine Y

C38H39N4O+ (567.3123704)


   

N-[(2R,3S)-2-[[[anilino(oxo)methyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

N-[(2R,3S)-2-[[[anilino(oxo)methyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C30H41N5O6 (567.3056686)


   

3-methoxy-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

3-methoxy-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C31H41N3O7 (567.2944356)


   

(3S,4aR,8aR)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide

(3S,4aR,8aR)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide

C32H45N3O4S (567.3130610000001)


   
   
   

[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C29H46NO8P (567.2960886)


   

helvolate

helvolate

C33H43O8 (567.2957778)


The steroid acid anion formed by loss of a proton from the carboxy group of helvolic acid; major microspecies at pH 7.3.

   

N-tert-butyl-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide

N-tert-butyl-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide

C32H45N3O4S (567.3130610000001)


   
   
   
   
   
   

(2z)-1-[(10r)-6-hydroxy-10-(4-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1,5,9-triazacyclotridec-5-en-1-yl]-3-phenylprop-2-en-1-one

(2z)-1-[(10r)-6-hydroxy-10-(4-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1,5,9-triazacyclotridec-5-en-1-yl]-3-phenylprop-2-en-1-one

C31H41N3O7 (567.2944356)


   

(2e)-1-[(10r)-6-hydroxy-10-(4-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1,5,9-triazacyclotridec-5-en-1-yl]-3-phenylprop-2-en-1-one

(2e)-1-[(10r)-6-hydroxy-10-(4-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1,5,9-triazacyclotridec-5-en-1-yl]-3-phenylprop-2-en-1-one

C31H41N3O7 (567.2944356)


   

(2e)-1-[(8s)-6-hydroxy-8-(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1,5,9-triazacyclotridec-5-en-1-yl]-3-phenylprop-2-en-1-one

(2e)-1-[(8s)-6-hydroxy-8-(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1,5,9-triazacyclotridec-5-en-1-yl]-3-phenylprop-2-en-1-one

C31H41N3O7 (567.2944356)


   

1-(6-hydroxy-8-{4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}-1,5,9-triazacyclotridec-5-en-1-yl)-3-phenylprop-2-en-1-one

1-(6-hydroxy-8-{4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}-1,5,9-triazacyclotridec-5-en-1-yl)-3-phenylprop-2-en-1-one

C31H41N3O7 (567.2944356)


   

(2z)-1-[(8s)-6-hydroxy-8-(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1,5,9-triazacyclotridec-5-en-1-yl]-3-phenylprop-2-en-1-one

(2z)-1-[(8s)-6-hydroxy-8-(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1,5,9-triazacyclotridec-5-en-1-yl]-3-phenylprop-2-en-1-one

C31H41N3O7 (567.2944356)